Post-Treatment Effects of Local GDNF Administration to the Inner Ears of Deafened Guinea Pigs
- 1 September 2010
- journal article
- research article
- Published by Mary Ann Liebert Inc in Journal of Neurotrauma
- Vol. 27 (9), 1745-1751
- https://doi.org/10.1089/neu.2009.1218
Abstract
For patients with profound hearing loss, a cochlear implant is the only treatment available today. The function of a cochlear implant depends in part on the function and survival of spiral ganglion neurons. Following deafferentation, glial cell-derived neurotrophic factor (GDNF) is known to affect spiral ganglion neuron survival. The purpose of this study was to assess delayed GDNF treatment after deafening, the effects of cessation of GDNF treatment, and the effects of subsequent antioxidants on responsiveness and survival of the spiral ganglion neurons. Three-week deafened (by local neomycin administration) guinea pigs were implanted in the scala tympani with a combined cochlear implant electrode and cannula. GDNF (1 μg/mL) or artificial perilymph was then delivered for 4 weeks, following which the animals received systemic ascorbic acid + Trolox® or saline for an additional 4 weeks. Thresholds for electrically-evoked auditory brain stem responses (eABRs) were significantly elevated at 3 weeks with deafness, stabilized with GDNF, and showed no change with GDNF cessation and treatment with antioxidants or saline. The populations of spiral ganglion neurons were reduced with deafness (by 40% at 3 weeks and 70% at 11 weeks), and rescued from cell death by GDNF with no further reduction at 8 weeks following 4 weeks of cessation of GDNF treatment equally in both the antioxidant- and saline-treated groups. Local growth factor treatment of the deaf ear may prevent deterioration in electrical responsiveness and rescue auditory nerve cells from death; these effects outlast the period of treatment, and may enhance the benefits of cochlear implant therapy for the deaf.Keywords
This publication has 19 references indexed in Scilit:
- Enhanced Survival of Spiral Ganglion Cells After Cessation of Treatment with Brain-Derived Neurotrophic Factor in Deafened Guinea PigsJournal of the Association for Research in Otolaryngology, 2009
- In vivo infusion of UTP and uridine to the deafened guinea pig inner ear: Effects on response thresholds and neural survivalJournal of Neuroscience Research, 2008
- Glial cell line-derived neurotrophic factor and antioxidants preserve the electrical responsiveness of the spiral ganglion neurons after experimentally induced deafnessNeurobiology of Disease, 2008
- Deafferentiation‐associated changes in afferent and efferent processes in the guinea pig cochlea and afferent regeneration with chronic intrascalar brain‐derived neurotrophic factor and acidic fibroblast growth factorJournal of Comparative Neurology, 2008
- Effects of antioxidants on auditory nerve function and survival in deafened guinea pigsNeurobiology of Disease, 2007
- Survival of Injured Spinal Motoneurons in Adult Rat upon Treatment with Glial Cell Line–Derived Neurotrophic Factor at 2 Weeks but Not at 4 Weeks after Root AvulsionJournal of Neurotrauma, 2006
- Clinical application of neurotrophic factors: the potential for primary auditory neuron protectionEuropean Journal of Neuroscience, 2005
- Chronic depolarization enhances the trophic effects of brain‐derived neurotrophic factor in rescuing auditory neurons following a sensorineural hearing lossJournal of Comparative Neurology, 2005
- Delayed neurotrophic treatment preserves nerve survival and electrophysiological responsiveness in neomycin‐deafened guinea pigsJournal of Neuroscience Research, 2004
- BDNF‐induced survival of auditory neurons in vivo: Cessation of treatment leads to accelerated loss of survival effectsJournal of Neuroscience Research, 2003